Inclusion Criteria:  Age between 25 and 75 years; In primary prevention for low-moderate CV risk, with diet and physical exercise to control raised LDL-C level, for at least 3 months; LDL-C > 100 mg/dL (2.6 mmol/L), < 190 mg/dL (4.9 mmol/L) CV risk SCORE <5% (based on SCORE chart according to figure I for Poland respective figure 2 for Austria and Germany in the ESC/EAS guideline 2019); Triglyceride <400 mg/dL; Advised to use nutraceutical as part of the lifestyle intervention as per guideline and within the product label (i.e. posology as in product label); Written informed consent.  Exclusion Criteria:  Subjects being treated or who have been treated for up to 3 months before the start of the study with lipid-lowering drugs or nutraceuticals including functional foods for which lipid-lowering effects are known (e.g. fish oil, sterol-containing yoghurts etc.); Subjects involved in other clinical studies with pharmaceutical products Known laboratory evidence of either liver, muscle, thyroid or kidney dysfunction; Subjects with prior history of cardiovascular events or with high cardiovascular risk equivalents; Uncontrolled hypertension (systolic blood pressure >190 mmHg or diastolic blood pressure >100 mmHg); Pregnancy and breastfeeding.